Skip to main content

Papers: The Genome of Schistosoma mansoni

There were a number of papers published today in Nature on the genome and some preliminary analysis of the pathogenic blood flukes Schistosoma mansoni and Schistosoma japonicum, these parasites are the causative agents of a variety of serious 'neglected' tropical endemic diseases - protypical of these is bilharzia (also known as snail fever, schistosomiasis or bilharziosis). Current drug treatment options are limited to Praziquantel and Oxamniquine. These blood flukes have that classic 'dual host' life-cycle initially infecting fresh water snails and then subsequently mammals - I remember seeing a diagram of this cycle in one of my first science books when I was about seven years old, and wondered how amazing and unbelievable that process was.

These genomes offer an important opportunity to identify potential sites of new therapeutic intervention. We at the EMBL-EBI contributed to the S. mansoni publication by performing a first pass 'therapeutic agent' and 'medicinal chemistry' annotation of the genome; uniquely this informatics analysis was performed essentially in 'real time' and contemporaneously with the final assembly of the complete gene set.

We will map out the general genome annotation strategy that we performed in a few future blog posts in the next week or so. More informally and extensively than could be done in the original publication.

A link to the S. mansoni paper is here (FREE MANUSCRIPT). Coverage in the broader media can be found here.

%J Nature 
%V 460
%P 352-358 
%D 16 July 2009
%O doi:10.1038/nature08160
%T The genome of the blood fluke Schistosoma mansoni
%A Matthew Berriman
%A B.J. Haas
%A P.T. LoVerde
%A R.A. Wilson
%A G.P. Dillon
%A G.C. Cerqueira
%A S.T. Mashiyama
%A B. Al-Lazikani
%A L.F. Andrade
%A P.D. Ashton
%A M.A. Aslett
%A D.C. Bartholomeu
%A G. Blandin
%A C.R. Caffrey
%A A. Coghlan
%A R. Coulson
%A T.A. Day
%A A. Delcher
%A R. DeMarco
%A A. Djikeng
%A T. Eyre
%A J.A. Gamble
%A E. Ghedin
%A Y. Gu
%A C. Hertz-Fowler
%A H. Hirai
%A Y. Hirai
%A R. Houston
%A A. Ivens
%A D.A. Johnston
%A D. Lacerda
%A C.D. Macedo
%A P. McVeigh
%A Z. Ning
%A G. Oliveira
%A J.P. Overington
%A J. Parkhill
%A M. Pertea
%A R.J. Pierce
%A A.V. Protasio
%A M.A. Quail
%A M.-A. Rajandream
%A J. Rogers
%A M. Sajid
%A S.L. Salzberg
%A M. Stanke
%A A.R. Tivey
%A O. White
%A D.L. Williams
%A J. Wortman
%A W. Wu
%A M. Zamania
%A A. Zerlotini
%A C.M. Fraser-Liggett
%A B.G. Barrell
%A N.M. El-Sayed

Comments

Popular posts from this blog

New SureChEMBL announcement

(Generated with DALL-E 3 ∙ 30 October 2023 at 1:48 pm) We have some very exciting news to report: the new SureChEMBL is now available! Hooray! What is SureChEMBL, you may ask. Good question! In our portfolio of chemical biology services, alongside our established database of bioactivity data for drug-like molecules ChEMBL , our dictionary of annotated small molecule entities ChEBI , and our compound cross-referencing system UniChem , we also deliver a database of annotated patents! Almost 10 years ago , EMBL-EBI acquired the SureChem system of chemically annotated patents and made this freely accessible in the public domain as SureChEMBL. Since then, our team has continued to maintain and deliver SureChEMBL. However, this has become increasingly challenging due to the complexities of the underlying codebase. We were awarded a Wellcome Trust grant in 2021 to completely overhaul SureChEMBL, with a new UI, backend infrastructure, and new f

A python client for accessing ChEMBL web services

Motivation The CheMBL Web Services provide simple reliable programmatic access to the data stored in ChEMBL database. RESTful API approaches are quite easy to master in most languages but still require writing a few lines of code. Additionally, it can be a challenging task to write a nontrivial application using REST without any examples. These factors were the motivation for us to write a small client library for accessing web services from Python. Why Python? We choose this language because Python has become extremely popular (and still growing in use) in scientific applications; there are several Open Source chemical toolkits available in this language, and so the wealth of ChEMBL resources and functionality of those toolkits can be easily combined. Moreover, Python is a very web-friendly language and we wanted to show how easy complex resource acquisition can be expressed in Python. Reinventing the wheel? There are already some libraries providing access to ChEMBL d

LSH-based similarity search in MongoDB is faster than postgres cartridge.

TL;DR: In his excellent blog post , Matt Swain described the implementation of compound similarity searches in MongoDB . Unfortunately, Matt's approach had suboptimal ( polynomial ) time complexity with respect to decreasing similarity thresholds, which renders unsuitable for production environments. In this article, we improve on the method by enhancing it with Locality Sensitive Hashing algorithm, which significantly reduces query time and outperforms RDKit PostgreSQL cartridge . myChEMBL 21 - NoSQL edition    Given that NoSQL technologies applied to computational chemistry and cheminformatics are gaining traction and popularity, we decided to include a taster in future myChEMBL releases. Two especially appealing technologies are Neo4j and MongoDB . The former is a graph database and the latter is a BSON document storage. We would like to provide IPython notebook -based tutorials explaining how to use this software to deal with common cheminformatics p

Multi-task neural network on ChEMBL with PyTorch 1.0 and RDKit

  Update: KNIME protocol with the model available thanks to Greg Landrum. Update: New code to train the model and ONNX exported trained models available in github . The use and application of multi-task neural networks is growing rapidly in cheminformatics and drug discovery. Examples can be found in the following publications: - Deep Learning as an Opportunity in VirtualScreening - Massively Multitask Networks for Drug Discovery - Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set But what is a multi-task neural network? In short, it's a kind of neural network architecture that can optimise multiple classification/regression problems at the same time while taking advantage of their shared description. This blogpost gives a great overview of their architecture. All networks in references above implement the hard parameter sharing approach. So, having a set of activities relating targets and molecules we can tra

Using ChEMBL activity comments

We’re sometimes asked what the ‘activity_comments’ in the ChEMBL database mean. In this Blog post, we’ll use aspirin as an example to explain some of the more common activity comments. First, let’s review the bioactivity data included in ChEMBL. We extract bioactivity data directly from   seven core medicinal chemistry journals . Some common activity types, such as IC50s, are standardised  to allow broad comparisons across assays; the standardised data can be found in the  standard_value ,  standard_relation  and  standard_units  fields. Original data is retained in the database downloads in the  value ,  relation  and  units  fields. However, we extract all data from a publication including non-numerical bioactivity and ADME data. In these cases, the activity comments may be populated during the ChEMBL extraction-curation process  in order to capture the author's  overall  conclusions . Similarly, for deposited datasets and subsets of other databases (e.g. DrugMatrix, PubChem), th